SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-199075
Filing Date
2019-07-22
Accepted
2019-07-22 17:09:04
Documents
11
Period of Report
2019-07-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d780262d8k.htm 8-K 26598
2 EX-4.1 d780262dex41.htm EX-4.1 292583
3 EX-4.2 d780262dex42.htm EX-4.2 500374
4 EX-99.1 d780262dex991.htm EX-99.1 8624
5 GRAPHIC g780262g0720045751687.jpg GRAPHIC 1740
6 GRAPHIC g780262g0720045751827.jpg GRAPHIC 2099
7 GRAPHIC g780262g0720045751936.jpg GRAPHIC 2101
8 GRAPHIC g780262g0720045752045.jpg GRAPHIC 2375
9 GRAPHIC g780262g0720045752155.jpg GRAPHIC 1922
10 GRAPHIC g780262g0720045752279.jpg GRAPHIC 2799
11 GRAPHIC g780262img.jpg GRAPHIC 18591
  Complete submission text file 0001193125-19-199075.txt   874274
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-14656 | Film No.: 19966333
SIC: 2836 Biological Products, (No Diagnostic Substances)